Previous Section
Review Articles
41. The metabolic syndrome in polycystic ovary syndrome.
- Author
- Essah PA; Wickham EP; Nestler JE;
- Institution
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia, USA. paessah@hsc.vcu.edu
- Journal
- Clin Obstet Gynecol. 2007 Mar;50(1):205-25.
- Abstract URL
- Click here to view abstract
42. Polycystic ovary syndrome: diagnosis and treatment.
- Author
- Setji TL; Brown AJ;
- Institution
- Department of Medicine, Division of Endocrinology, Duke University Medical Center, Durham, NC 27710, USA. setji001@mc.duke.edu
- Journal
- Am J Med. 2007 Feb;120(2):128-32.
- Abstract URL
- Click here to view abstract
43. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
- Author
- Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N;
- Institution
- School of Women's & Children's Health, Royal Hospital for Women, Division of Obstetrics & Gynaecology, Barker Street, Randwick, Sydney, Australia, NSW 2031. mfcostello@unsw.edu.au
- Journal
- Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005552.
- Abstract URL
- Click here to view abstract
44. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.
- Author
- Teede HJ; Hutchison S; Zoungas S; Meyer C;
- Institution
- Jean Hailes Research Group, Monash University Institute of Health Services Research and Diabetes Unit Southern Health, Melbourne, Australia. helena.teede@med.monash.edu.au
- Journal
- Endocrine. 2006 Aug;30(1):45-53.
- Abstract URL
- Click here to view abstract
45. Lifestyle choices, diet, and insulin sensitizers in polycystic ovary syndrome.
- Author
- Norman RJ; Homan G; Moran L; Noakes M; Norman RJ; Homan G; Moran L; Noakes M;
- Institution
- Department of Obstetrics and Gynaecology, Research Centre for Reproductive Health, University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia. Robert.Norman@adelaide.edu.au
- Journal
- Endocrine. 2006 Aug;30(1):35-43.
- Abstract URL
- Click here to view abstract
46. Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment.
- Author
- Gorry A; White DM; Franks S; Gorry A; White DM; Franks S;
- Institution
- Institute of Reproductive & Developmental Biology, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.
- Journal
- Endocrine. 2006 Aug;30(1):27-33.
- Abstract URL
- Click here to view abstract
47. Stress in women: metabolic syndrome and polycystic ovary syndrome.
- Author
- Diamanti-Kandarakis E; Economou F;
- Institution
- First Department of Internal Medicine, Athens University School of Medicine, Laiko General Hospital, Greece. akandara@otenet.gr
- Journal
- Ann N Y Acad Sci. 2006 Nov;1083:54-62.
- Abstract URL
- Click here to view abstract
48. Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
- Author
- Cheang KI; Sharma ST; Nestler JE;
- Institution
- Department of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298-0111, USA.
- Journal
- Gynecol Endocrinol. 2006 Nov;22(11):595-604.
- Abstract URL
- Click here to view abstract
49. Update on the management of polycystic ovary syndrome.
- Author
- Krysiak R; Okopien B; Gdula-Dymek A; Herman ZS;
- Institution
- Department of Clinical Pharmacology, Silesian University School of Medicine, Medykow 18, PL 40-752 Katowice, Poland. r.krysiak@pharmanet.com.pl
- Journal
- Pharmacol Rep. 2006 Sep-Oct;58(5):614-25.
- Abstract URL
- Click here to view abstract
50. Polycystic ovary syndrome.
- Author
- King J;
- Institution
- Emory University School of Nursing, Atlanta, GA 30322, USA. jking01@emory.edu <jking01@emory.edu>
- Journal
- J Midwifery Womens Health. 2006 Nov-Dec;51(6):415-22.
- Abstract URL
- Click here to view abstract
